PACS PACS Group, Inc.
XNYS
48.79
Delayed
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
PACS
$48.79
—
What changed
Recent filings, trades and movesKey stats
$48.79
- 52-Week Range
- $10.31 – $51.68
- YTD
- +23.49%
- IV Rank (30D)
- 6.13
- Straddle Price
- $5.95
- P/C Vol Ratio
- 0.22
- Market Cap
- $7.7B
- Open
- $48.96
- Day Range
- $48.52 – $49.75
- Volume
- 39,165
- Prev Close
- $49.10
Fair Value
MODEL: SHORT
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 4.84% |
| Beta vs SPY | 0.33 |
| Cost of Equity (CAPM) | 6.49% (VRP-adj) |
| WACC | 6.55% |
| Volatility Risk Premium | +37.1pp (IV − HV30) |
| Effective Tax Rate | 30.2% |
| Rev. Growth (YoY, DCF input) | +10.4% |
| DCF Horizon | 10 years explicit + fade |
| Forward Tilt (NTM/TTM) | ×1.10 (applied to P/E, EV/EBITDA, P/S) |
| Free Cash Flow (TTM) | $0.0B |
| Return on Equity (TTM) | 22.9% |
| Book / Price | 15.2% |
| Gross Margin (TTM) | 22.2% |
| FCF Margin (TTM) | 0.1% |
| Debt / Equity | 0.22 |
| Quality Score | 2/6 — normal (10y DCF) |
| SMA 50 | $44.73 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $47.69 |
| Bollinger Width / SMA20 | 13.7% (drives anchor stability) |
| Net Debt | $0.1B |
| Market Cap | $8B |
Peers used for multiples: AGL, BTSG, CNC, GH, HUM, ROIV, RVMD, UNH
60-Day Conviction
94%
20-Day Fair Value
≈ by Dec 9, 2026
$47.75
α -1.4%
rank 6%
conviction
81%
40-Day Fair Value
≈ by Jan 7, 2027
$47.31
α -2.3%
rank 6%
conviction
69%
60-Day Fair Value
≈ by Feb 5, 2027
$45.52
α -6.0%
rank 6%
conviction
94%
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | $1.18 | 26% | |
| DDM (Gordon) | n/a | 0% | |
| Peer P/E | $57.00 | 11% | median 28.8× · 4 peers |
| Peer EV/EBITDA | $59.49 | 11% | median 18.1× · 4 peers |
| Peer P/B | $45.65 | 2% | median 6.1× · 7 peers |
| Peer P/S | $31.97 | 8% | median 0.8× · 8 peers |
| Market Anchor (SMA50) | $44.73 | 42% | stability 81% (BB-width) |
| Options Expected (B-L 30d) | $49.45 | 0% | 7 strikes · skew +0.67 |
As of 2026-11-10 · updated
Related
About
- Industry (SIC)
- SERVICES-SKILLED NURSING CARE FACILITIES (8051) · industry map
- Exchange
- XNYS
- Market Cap
- $7.7B
- Employees
- 47,455
- List Date
- 2024-04-11
- CIK
- 0002001184
- Last Earnings
- Nov 3 after close · +7.7% vs ±16.9% expected
- Headquarters
- Salt Lake City, UT
- Homepage
- https://www.pacs.com
PACS Group Inc is a post-acute healthcare company mainly focused on delivering skilled nursing care through a portfolio of independently operated facilities. The post-acute care ecosystem serves individuals who need additional help recuperating from acute conditions, illnesses, or serious medical procedures after getting discharged from the hospital. It also provides senior care, assisted living, and independent living options in some of the communities. The company has one reportable segment.
Summary
—
composite
—
No summary data available for this symbol yet.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
Chart
Seasonality
| Month | '24 | '25 | '26 | Avg |
|---|---|---|---|---|
| Jan | -- | 12.37% | -14.55% | -1.09% |
| Feb | -- | -9.07% | 3.14% | -2.96% |
| Mar | -- | -13.94% | -15.03% | -14.48% |
| Apr | 8.57% | -11.24% | 5.94% | 1.09% |
| May | 22.19% | 2.06% | 11.06% | 11.77% |
| Jun | -3.18% | 31.70% | 19.98% | 16.17% |
| Jul | 22.39% | -14.59% | 3.42% | 3.74% |
| Aug | 11.00% | 9.60% | -4.92% | 5.23% |
| Sep | 1.11% | 18.46% | -1.40% | 6.06% |
| Oct | 9.77% | -13.90% | 16.52% | 4.13% |
| Nov | -63.18% | 183.38% | 6.20%* | 42.13% |
| Dec | -17.55% | 14.53% | -- | -1.51% |
| Total | -41.21% | 225.09% | 26.83% | 70.24% |
* Only 3 year(s) of data available.
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $48.13
SMA 50: $45.00
SMA 200: $40.21
Current: $49.09
EMA 12: $48.55
EMA 26: $47.32
MACD: 1.2329 | Signal: -0.0284
BULLISH
ADX (14): 28.26
TREND
+DI: 24.91
−DI: 15.06
Momentum Oscillators
RSI (14): 57.59
NEUTRAL
Stoch %K: 57.21
Stoch %D: 60.93
Williams %R: -41.10
Volume & Volatility
BB Upper: $50.78
BB Lower: $45.47
NEUTRAL
OBV: 41,904,504
Vol SMA 20: 929,538
Vol ROC: -94.92%
ATR: $1.99
True Range: $1.23
HV 20: 49.2%
HV 30: 42.5%
HV 60: 36.9%
Data Summary
Data Points: 500
Last Updated:
Date Range: 2024-11-12T00:00:00 – 2026-11-10T00:00:00
AI Analysis
Written before PACS’s Nov 3 earnings report, so it doesn’t reflect the results.
LLM Stock Analysis Report for PACS
Executive Summary
Overall Assessment: NEUTRAL (confidence level: 6/10)
Key Drivers:
- Bullish momentum signals from MACD and RSI
- Strong support at $34.51 SMA 20
- Low volatility compared to market
Primary Risks:
- Overbought conditions with RSI above 70
- Recent news sentiment neutral, lacks clear catalysts
Investment Thesis: PACS is trading in a strong uptrend, driven by bullish momentum indicators. The stock has a low volatility profile, which reduces the risk of sudden price movements. However, overbought conditions and lack of clear catalysts suggest caution.
Recent News Sentiment Impact: The neutral news sentiment has not significantly impacted the stock's price movement recently.
Technical Analysis
Trend Direction: Short-term: Uptrend (1-4 weeks) Medium-term: Uptrend (1-3 months) Long-term: Uptrend (3-12 months)
Support/Resistance Levels:
- SMA 20: $34.51
- SMA 50: $23.92
- Upper Bollinger Band: $40.32
Momentum Signals: RSI interpretation: Overbought (>70) with RSI value at 86.37 MACD signal: Bullish crossover above signal line Bollinger Bands position: Neutral, neither squeezing nor breaking out
Volume Analysis: Volume SMA 20: 1115269.35 On-Balance Volume (OBV): 51263042.00 Volume Rate of Change: -53.13%
News & Sentiment Analysis
Recent Headlines Summary:
- PACS Group stock hits 52-week high at 39.42 USD (Investing.com India, 2025-12-30) - Neutral sentiment
- Biggest Stock Movers Today, Nov. 20: PACS, BBWI, & More (AOL.com, 2025-12-29) - Neutral sentiment
Sentiment Assessment: Neutral
Catalyst Identification: No clear catalysts in recent news headlines
Market Narrative: The market narrative remains neutral, with no significant news driving the stock's price movement.
Risk & Volatility Assessment
Beta Interpretation: Low risk (beta: 0.64) compared to SPY
Volatility Regime: Current volatility is low compared to historical levels
Options Market Signals: IV Rank: 37.2% (Medium) Current IV: 141.8% Expected Move: $5.82 (17 DTE), 7-DTE: $5.82 Volume Flow: 509 calls vs 61 puts Open Interest: 9,800 calls vs 1,285 puts Put/Call Volume Ratio: 0.12 (Bullish sentiment) Put/Call OI Ratio: 0.13 Market Expectation: Options market pricing $5.82 move by expiration
Downside Protection: Support at SMA 20 ($34.51)
Market Context & Positioning
Sector Performance: Relative strength vs sector/market (neutral)
Institutional Activity: Volume patterns suggesting institutional interest, but no clear buying or selling pressure
Correlation Analysis: Low correlation with market (R-squared interpretation: 0.13)
Relative Valuation: Position within trading range, with potential for further upside
Key Levels & Action Items
Critical Price Levels:
- SMA 20: $34.51 (support)
- Upper Bollinger Band: $40.32 (resistance)
Breakout/Breakdown Levels: None identified
Time-Sensitive Catalysts: Earnings date (2025-11-19), product launch or regulatory change could impact the stock's price movement
Risk Management: Stop-loss levels at SMA 20 ($34.51) and position sizing considerations based on risk tolerance.
Please note that this analysis is based on the provided data, and actual results may vary depending on future market movements and news sentiment.
Generated
News
All PACS news →
Crypto super PACs spent more than $176 million on the midterms, but the Democratic sweep raises the prospect of tougher industry scrutiny.
Showing 1–10 of 30
Page 1 of 3
Earnings History
5 of 9 under expected move
Avg Expected Move
17.30%
Avg Actual Move
15.89%
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2024-05-13 | After-Close | 6.58% | 7.30% | 1.11x | Exceeded |
| 2024-08-12 | After-Close | 11.05% | 18.79% | 1.70x | Exceeded |
| 2024-11-06 | After-Close | 28.33% | 9.62% | 0.34x | Within |
| 2025-09-11 | After-Close | 12.50% | 1.56% | 0.12x | Within |
| 2025-11-19 | After-Close | 31.34% | 55.32% | 1.77x | Exceeded |
| 2026-02-26 | After-Close | 19.50% | 12.38% | 0.63x | Within |
| 2026-05-11 | After-Close | 13.64% | 28.56% | 2.09x | Exceeded |
| 2026-08-04 | After-Close | 15.90% | 1.85% | 0.12x | Within |
| 2026-11-03 | After-Close | 16.87% | 7.67% | 0.45x | Within |
Earnings calendar: this week’s reports with expected vs actual moves →
PACS Options Activity & IV Rank
PACS IV rank history, 52-week IV rank and IV percentile →
Volatility Metrics
Current IV: 48.5%
7-DTE IV: 58.1%
Expected Move: $5.95
7-DTE Move: $3.67
Days to Exp: 37 (2026-12-18)
Options Flow · All expiries
Call Volume: 3,282
Put Volume: 715
P/C Volume: 0.218
BULLISH
Call OI: 48,108
Put OI: 7,143
P/C OI: 0.148
Total OI: 55,251
ATM Options Pricing
ATM Call: $2.60
ATM Put: $3.35
Call %: 5.3%
Put %: 6.9%
Chain Summary
Chain Volume: 3,997
Chain OI: 55,251
Last Updated: 11/11/2026
Spread Scanner
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Calendars: the long leg is valued at the short leg’s expiration (Black-Scholes at its current IV) across the range of prices the short leg’s IV implies, giving the best-case profit (R/R = that over the debit) and P(profit).
Stage 2 — Skew Adjustment (±25% cap)
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Scanning bull put, bear call, iron condor and calendar spreads…
Dealer Positioning
HIGH γ vs HISTORY
Estimated net dealer gamma is at the 98th percentile of this name's own daily history, near the high end of its range. This describes current positioning; it is not a forecast or a trading signal.
Gamma percentile
98%
vs own history
GEX tilt
+0.93
OI-weighted, today
Vanna tilt
+0.66
δ-sensitivity to IV
Charm tilt
-0.50
δ-decay vs time
Vanna tilt +0.66: the estimated dealer exposure leans positive, so the modeled hedge would shift noticeably if implied volatility changed.
Charm tilt -0.50: the estimated dealer exposure leans negative, so the modeled hedge would shift noticeably as time passes and options approach expiry.
? What is this?
· 14 ATM contracts, 18k total OI
Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.
Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.
Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.
This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Wing vs ATM
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
—
—
pts
EXTREME
No data
30 DTE / 10d
—
—
pts
EXTREME
No data
Extreme reading.
Historically these have been contrarian — on the small set of observed earnings-day cases, large negative wing-vs-ATM gaps (calls pricing much richer than puts at the same delta) preceded sharp drops in the underlying within 1-12 days. Not financial advice and the dataset is small.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Volatility Surface
Loading the implied volatility surface…
Volatility Smile
Loading the implied volatility smile…
IV Rank (7 DTE)19.6LowNov 11
IV Rank (30 DTE)6.1LowNov 11
Straddle Price (30 DTE)$5.95Nov 11
Beta Analysis
Risk Metrics
Beta: 0.3081
Alpha: 169.33%
Correlation: 0.0452
R-Squared: 0.2%
Stock Volatility: 93.4%
Market Volatility: 13.7%
Analysis Details
Benchmark: SPY
Data Points: 251
Period: 252 trading days
Data Points: 251
Period: 252 trading days
Interpretation:
Low volatility - stock moves less than market
Low volatility - stock moves less than market
Beta & Alpha Over Time
Notable investors who own PACS
3 of 37 tracked investors
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Citadel Hedge fund Ken Griffin | $6.2M | #1931 of 6285 | -76.5% | 13F | |
| Millennium Management Hedge fund Izzy Englander | $3.1M | #2336 of 3716 | -81.2% | 13F | |
| Rockefeller Capital Management Family office Rockefeller family | $2K | #4424 of 4729 | new | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
PACS Institutional Ownership (13F)
Filings for 2026-06-30 · 102 already for 2026-09-30
? 13F Guide
Diluted shares outstanding: 154,545,977 (as of 2026-09-30)
Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
8 filers$80.44M notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Susquehanna International Group, LLP Custodian | $40.39M | 50.22% | 2026-06-30 |
| 2 | Citadel Advisors LLC Custodian | $21.12M | 26.26% | 2026-06-30 |
| 3 | GROUP ONE TRADING LLC Custodian | $7.01M | 8.71% | 2026-06-30 |
| 4 | IMC-Chicago, LLC Custodian | $4.60M | 5.72% | 2026-09-30 |
| 5 | Jane Street Group, LLC Custodian | $3.48M | 4.33% | 2026-06-30 |
| 6 | Simplex Trading, LLC Custodian | $1.97M | 2.44% | 2026-09-30 |
| 7 | PEAK6 LLC | $1.63M | 2.02% | 2026-06-30 |
| 8 | Point72 Asset Management, L.P. | $243.05K | 0.30% | 2026-06-30 |
8 filers$14.36M notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | IMC-Chicago, LLC Custodian | $3.64M | 25.32% | 2026-09-30 |
| 2 | Citadel Advisors LLC Custodian | $3.63M | 25.28% | 2026-06-30 |
| 3 | Susquehanna International Group, LLP Custodian | $2.09M | 14.55% | 2026-06-30 |
| 4 | Simplex Trading, LLC Custodian | $1.90M | 13.23% | 2026-09-30 |
| 5 | GROUP ONE TRADING LLC Custodian | $1.54M | 10.69% | 2026-06-30 |
| 6 | Jane Street Group, LLC Custodian | $916.76K | 6.39% | 2026-06-30 |
| 7 | Crawford Fund Management, LLC | $596.96K | 4.16% | 2026-06-30 |
| 8 | Point72 Asset Management, L.P. | $55.43K | 0.39% | 2026-06-30 |
PACS Insider Trading (Form 4)
Latest: 2026-11-09Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-11-09 | Jason Hulse Murray | Co-Founder, CEO & Chairman | Sell (S) | −19,235 | $50.64 | -$974.0K | EDGAR |
| 2026-11-04 | Michelle Renee Lewis | Chief Accounting Officer | Sell (S) | −3,172 | $50.06 | -$158.8K | EDGAR |
| 2026-11-04 | Jason Hulse Murray | Co-Founder, CEO & Chairman | Sell (S) | −225,296 | $49.21 | -$11.09M | EDGAR |
| 2026-11-04 | Mark Hancock | Director | Sell (S) | −186,696 | $50.45 | -$9.42M | EDGAR |
| 2026-10-30 | Jason Hulse Murray | Co-Founder, CEO & Chairman | Sell (S) | −8,803 | $50.09 | -$440.9K | EDGAR |
| 2026-10-30 | Mark Hancock | Director | Sell (S) | −13,304 | $50.08 | -$666.2K | EDGAR |
| 2026-10-30 | Michelle Renee Lewis | Chief Accounting Officer | Sell (S) | −11,828 | $50.11 | -$592.6K | EDGAR |
| 2026-10-26 | Jason Hulse Murray | Co-Founder, CEO & Chairman | Sell (S) | −82,613 | $48.42 | -$4.00M | EDGAR |
| 2026-10-21 | Jason Hulse Murray | Co-Founder, CEO & Chairman | Sell (S) | −45,707 | $47.64 | -$2.18M | EDGAR |
| 2026-10-16 | Jason Hulse Murray | Co-Founder, CEO & Chairman | Sell (S) | −118,729 | $47.29 | -$5.61M | EDGAR |
| 2026-10-16 | Joshua Jergensen | President & COO | Sell (S) | −40,000 | $44.50 | -$1.78M | EDGAR |
| 2026-10-07 | Jason Hulse Murray | Co-Founder, CEO & Chairman | Sell (S) | −36,692 | $43.08 | -$1.58M | EDGAR |
| 2026-10-05 | Jason Hulse Murray | Co-Founder, CEO & Chairman | Sell (S) | −83,308 | $42.00 | -$3.50M | EDGAR |
| 2026-09-17 | Joshua Jergensen | President & COO | Sell (S) | −40,000 | $43.13 | -$1.73M | EDGAR |
| 2026-09-15 | Mark Hancock | Director | Sell (S) | −300,000 | $43.48 | -$13.04M | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
PACS Insider Holdings
15 insiders · @ $49.09
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Jason Hulse Murray | Co-Founder, CEO & Chairman | 63,436,279 | $3.11B | -$380.85M | 18 | 2026-11-09 |
| 2 | Mark Hancock | Director | 62,818,884 | $3.08B | -$379.46M | 16 | 2026-11-04 |
| 3 | Joshua Jergensen | President & COO | 2,456,320 | $120.59M | -$8.38M | 11 | 2026-10-16 |
| 4 | Peter Sanford | See Remarks | 1,280,872 | $62.88M | $0 | 2 | 2025-04-16 |
| 5 | Derick G Apt | Chief Financial Officer | 1,111,628 | $54.58M | $0 | 2 | 2025-04-16 |
| 6 | John Todd Mitchell | Chief Legal Officer & Sec. | 830,955 | $40.80M | -$7.79M | 8 | 2026-05-19 |
| 7 | Joseph Robert Lee | Chief Compliance Officer | 648,122 | $31.82M | $0 | 2 | 2025-04-16 |
| 8 | Michelle Renee Lewis | Chief Accounting Officer | 340,338 | $16.71M | -$2.03M | 10 | 2026-11-04 |
| 9 | Carey P Hendrickson | Chief Financial Officer | 48,426 | $2.38M | $0 | 1 | 2026-05-15 |
| 10 | Trent Dean Bingham | Chief Human Resources Officer | 39,649 | $1.95M | $0 | 2 | 2026-03-26 |
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
PACS Board & Officers
As of SEC filings through Nov 9, 2026Directors 6
- Jacqueline Millard · since Apr 11, 2024
- Jason Hulse Murray · since Apr 11, 2024
- Mark Hancock · since Apr 11, 2024
- Taylor S. Leavitt · since Apr 11, 2024
- Evelyn S Dilsaver · since May 9, 2024
- Patrick Hugh Conway · since Mar 4, 2026
Officers 7
- Jason Hulse Murray · Co-Founder, CEO & Chairman · since Apr 11, 2024
- Joshua Jergensen · President & COO · since Apr 11, 2024
- Carey P Hendrickson · Chief Financial Officer · since Apr 27, 2026
- Michelle Renee Lewis · Chief Accounting Officer · since Apr 11, 2024
- Kelly Priegnitz · Chief Compliance Officer · since Feb 24, 2026
- Trent Dean Bingham · Chief Human Resources Officer · since Feb 24, 2026
- Patrick (Joseph) Murphy · Chief Legal Officer & Sec. · since Sep 21, 2026
10% owners 2
- Jason Hulse Murray · since Apr 11, 2024
- Mark Hancock · since Apr 11, 2024
Changes in the last 10 years (26)
| Sep 21, 2026 | Patrick (Joseph) Murphy became Chief Legal Officer & Sec. |
| Sep 18, 2026 | The company announced the departure of John Todd Mitchell as Chief Legal Officer & Sec. in an SEC filing |
| Jul 6, 2026 | Mark Hancock no longer listed as Co Fndr; Exec V Chair in SEC filings |
| Jun 17, 2026 | Mark Hancock listed as Co Fndr; Exec V Chair (previously Co Fndr; Int CFO; Exec V Chair) in SEC filings |
| Apr 27, 2026 | Carey P Hendrickson became Chief Financial Officer |
| Mar 4, 2026 | Patrick Hugh Conway became a director |
| Feb 24, 2026 | Trent Dean Bingham became Chief Human Resources Officer |
| Feb 24, 2026 | Kelly Priegnitz became Chief Compliance Officer |
| Dec 19, 2025 | Mark Hancock listed as Co Fndr; Int CFO; Exec V Chair (previously Co-Founder & Exec. Vice Chair.) in SEC filings |
| Sep 2, 2025 | The company announced the departure of Derick G Apt as Chief Financial Officer in an SEC filing |
| Aug 15, 2025 | The company announced the departure of Peter Sanford as President, Providence Administrative Consulting Services, Inc. in an SEC filing |
| May 9, 2024 | Evelyn S Dilsaver became a director |
| Apr 11, 2024 | Taylor S. Leavitt became a director |
| Apr 11, 2024 | Peter Sanford became President, Providence Administrative Consulting Services, Inc. |
| Apr 11, 2024 | Michelle Renee Lewis became Chief Accounting Officer |
| Apr 11, 2024 | Mark Hancock became a director |
| Apr 11, 2024 | Mark Hancock became a 10% owner |
| Apr 11, 2024 | Mark Hancock became Co-Founder & Exec. Vice Chair. |
| Apr 11, 2024 | Joshua Jergensen became President & COO |
| Apr 11, 2024 | Joseph Robert Lee became Chief Compliance Officer |
| Apr 11, 2024 | John Todd Mitchell became Chief Legal Officer & Sec. |
| Apr 11, 2024 | Jason Hulse Murray became a director |
| Apr 11, 2024 | Jason Hulse Murray became a 10% owner |
| Apr 11, 2024 | Jason Hulse Murray became Co-Founder, CEO & Chairman |
| Apr 11, 2024 | Jacqueline Millard became a director |
| Apr 11, 2024 | Derick G Apt became Chief Financial Officer |
Not reported recently (1)
- Joseph Robert Lee · Last reported as Chief Compliance Officer in an SEC filing dated Apr 16, 2025
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
PACS Proposed Insider Sales (Form 144)
Latest: 2026-11-06
? Form 144 Guide
Last 30d:
7 filings
· $51.2M notice value
· Last 90d:
12 filings
· $97.4M notice value
· 5 unique filers
· 92% under 10b5-1 plans
What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.
How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.
10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.
"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.
Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.
Top 90-day filers:
Murray Jason Hulse (4, $51.7M) · Hancock Mark (5, $23.1M) · John Mitchell (1, $16.9M) · Jergensen Joshua (1, $5.0M) · Michelle Renee Lewis (1, $718K)
| Filed | Filer | Role | Shares | Notice Value | Planned Sale | Broker | Plan | Link |
|---|---|---|---|---|---|---|---|---|
| 2026-11-06 | John Mitchell | Officer | 336,312 | $16.88M | 2026-11-06 | J.P. Morgan Securities LLC | — | EDGAR |
| 2026-11-04 | Hancock Mark | Officer, Director, 10% Stockholder | 186,696 | $9.42M | 2026-11-04 | Citigroup Global Markets Inc | 10b5-1 | EDGAR |
| 2026-10-29 | Hancock Mark | Officer, Director, 10% Stockholder | 4,280 | $214.1K | 2026-10-29 | Citigroup Global Markets Inc | 10b5-1 | EDGAR |
| 2026-10-28 | Hancock Mark | Officer, Director, 10% Stockholder | 9,024 | $452.1K | 2026-10-28 | Citigroup Global Markets Inc | 10b5-1 | EDGAR |
| 2026-10-28 | Michelle Renee Lewis | Officer | 15,000 | $717.8K | 2026-10-28 | J.P. Morgan Securities LLC | 10b5-1 | EDGAR |
| 2026-10-16 | Murray Jason Hulse | Officer, Director, 10% Stockholder | 386,667 | $18.52M | 2026-10-16 | UBS Financial Services, Inc. | 10b5-1 | EDGAR |
| 2026-10-14 | Jergensen Joshua | Officer | 132,519 | $5.00M | 2026-10-14 | THE CHARLES SCHWAB CORPORATION | 10b5-1 | EDGAR |
| 2026-09-15 | Hancock Mark | Officer, Director, 10% Stockholder | 155,682 | $6.61M | 2026-09-15 | Citigroup Global Markets Inc | 10b5-1 | EDGAR |
| 2026-09-15 | Hancock Mark | Officer, Director, 10% Stockholder | 144,318 | $6.43M | 2026-09-14 | Citigroup Global Markets Inc | 10b5-1 | EDGAR |
| 2026-09-10 | Murray Jason Hulse | Officer, Director, 10% Stockholder | 253,333 | $11.21M | 2026-09-10 | UBS Financial Services, Inc. | 10b5-1 | EDGAR |
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed. Market-wide feed: Planned sales (Form 144).
Recent SEC Filings
Latest: 2026-11-03
Current reports — material events the company must disclose within 4 business days (earnings releases, M&A, executive changes, etc.).
Annual report — audited financial statements, MD&A, risk factors. Filed 60–90 days after fiscal year-end.
| Filing Date | Accession | Link |
|---|
ETF Holders
95 ETFs hold PACS
25 shown · $412.12M total exposure · 0.07% AUM-weighted avg weight
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | VTI Vanguard Morningstar Total Stock Market ETF | Vanguard | 0.00% | $62.7M | — | 2026-09-30 |
| 2 | IWM iShares Russell 2000 ETF | iShares (BlackRock) | 0.08% | $59.9M | $77.9B | 2026-11-06 |
| 3 | AVUV Avantis U.S. Small Cap Value ETF | Avantis | 0.17% | $52.6M | $31.6B | 2026-11-06 |
| 4 | VB Vanguard Morningstar Small-Cap ETF | Vanguard | 0.03% | $44.5M | — | 2026-09-30 |
| 5 | DFAS Dimensional US Small Cap ETF | Dimensional | 0.09% | $30.9M | — | 2026-11-06 |
| 6 | VXF Vanguard Extended Market ETF | Vanguard | 0.02% | $22.2M | — | 2026-09-30 |
| 7 | IWO iShares Russell 2000 Growth ETF | iShares (BlackRock) | 0.16% | $21.8M | $14.2B | 2026-11-06 |
| 8 | VBR Vanguard Morningstar Small-Cap Value ETF | Vanguard | 0.02% | $14.5M | — | 2026-09-30 |
| 9 | DFAC Dimensional US Core Equity 2 ETF | Dimensional | 0.02% | $13.4M | — | 2026-11-06 |
| 10 | VBK Vanguard Morningstar Small-Cap Growth ETF | Vanguard | 0.03% | $12.4M | — | 2026-09-30 |
| 11 | VTWO Vanguard Russell 2000 ETF | Vanguard | 0.06% | $11.2M | — | 2026-09-30 |
| 12 | SCHA Schwab U.S. Small-Cap ETF | Nport | 0.04% | $8.9M | — | 2026-08-31 |
| 13 | DUSG Dimensional US Small Cap Growth ETF | Dimensional | 0.43% | $8.1M | — | 2026-11-06 |
| 14 | FNX First Trust Mid Cap Core AlphaDEX® Fund | First Trust | 0.43% | $6.0M | $1.4B | 2026-11-06 |
| 15 | VHT Vanguard Health Care ETF | Vanguard | 0.03% | $5.5M | — | 2026-09-30 |
| 16 | FNY First Trust Mid Cap Growth AlphaDEX® Fund | First Trust | 0.91% | $4.9M | $535.3M | 2026-11-06 |
| 17 | IHF iShares U.S. Healthcare Providers ETF | iShares (BlackRock) | 0.29% | $4.5M | $1.5B | 2026-11-06 |
| 18 | XHS State Street® SPDR® S&P® Health Care Services ETF | SPDR (State Street) | 1.83% | $4.4M | $241.2M | 2026-11-06 |
| 19 | PSC Principal U.S. Small-Cap ETF | Nport | 0.19% | $4.4M | — | 2026-06-30 |
| 20 | VFMO Vanguard U.S. Momentum Factor ETF | Vanguard | 0.21% | $3.7M | — | 2026-11-06 |
| 21 | AVLV Avantis U.S. Large Cap Value ETF | Avantis | 0.02% | $3.5M | $22.2B | 2026-11-06 |
| 22 | ITOT iShares Core S&P Total U.S. Stock Market ETF | iShares (BlackRock) | 0.00% | $3.1M | $95.6B | 2026-11-06 |
| 23 | PTH Invesco Dorsey Wright Healthcare Momentum ETF | Nport | 1.33% | $3.1M | — | 2026-07-31 |
| 24 | USVM VictoryShares US Small Mid Cap Value Momentum ETF | Nport | 0.18% | $3.1M | — | 2026-06-30 |
| 25 | FSMD Fidelity Small-Mid Multifactor ETF | Fidelity | 0.12% | $2.9M | $2.4B | 2026-11-06 |
Fundamentals
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
Metrics
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
Trailing P/E
27.17
TTM Diluted EPS
$1.80
TTM Revenue
$5.71B
TTM Net Income
$277.58M
TTM Op. Cash Flow
$579.69M
Quarterly figures (10 quarters)
| Quarter | Period End | Revenue | Net Income | Diluted EPS | Op. Cash Flow |
|---|---|---|---|---|---|
| Q3 '26 | 2026-09-30 | $1.50B | $60.82M | $0.37 | $211.24M |
| Q2 '26 | 2026-06-30 | $1.43B | $76.37M | $0.47 | $135.51M |
| Q1 '26 | 2026-03-31 | $1.42B | $80.69M | $0.50 | $236.34M |
| Q4 '25 | 2025-12-31 | $1.36B | $59.70M | $0.42 | $-3.39M |
| Q3 '25 | 2025-09-30 | $1.34B | $52.41M | $0.32 | $204.80M |
| Q2 '25 | 2025-06-30 | $1.31B | $50.96M | $0.31 | $52.57M |
| Q1 '25 | 2025-03-31 | $1.28B | $28.47M | $0.17 | $150.24M |
| Q4 '24 | 2024-12-31 | $1.21B | $37.20M | $0.25 | $64.59M |
| Q3 '24 | 2024-09-30 | $1.03B | $15.62M | $0.10 | $209.23M |
| Q2 '24 | 2024-06-30 | $935.71M | $-31.88M | $-0.21 | $34.77M |
Q3 2026 • period ending 2026-09-30 • filed 2026-11-03
Valuation
Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.
Price Multiples
- P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
- P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
- P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
- EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
- EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
- ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
- ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
- Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
- FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
- Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
- Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
- Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
- Multiples expanding while earnings are flat = sentiment-driven rally.
- Multiples compressing while earnings grow = value coming from fundamentals.
P/E
27.17
P/B
7.07
P/S
1.42
EV/EBITDA
16.65
EV/Sales
1.43
ROE
24.1%
ROA
4.8%
Div Yield
0.60%
FCF Yield
7.26%
Debt/Equity
0.21
Current Ratio
—
Market Cap
$7.89B
as of 2026-11-11
PACS vs Peers
Related companies, largest first| Company | Market cap | P/E | Revenue growth | YTD | IV rank |
|---|---|---|---|---|---|
| UNH UNITEDHEALTH GROUP INCORPORATED (Delawar | $356.3B | 30.0 | +9.7% | +18.0% | 43 |
| HUM Humana Inc. | $50.8B | 41.8 | +18.5% | +67.6% | 11 |
| RVMD Revolution Medicines, Inc. Common Stock | $43.3B | — | — | +142.1% | 57 |
| CNC Centene Corporation | $33.9B | 24.1 | +9.7% | +68.1% | 33 |
| ROIV Roivant Sciences Ltd. Common Shares | $29.5B | — | −67.6% | +89.3% | 41 |
| GH Guardant Health, Inc. Common Stock | $21.5B | — | +42.7% | +57.9% | 22 |
| BTSG BrightSpring Health Services, Inc. Commo | $13.8B | 51.0 | +28.0% | +87.3% | 22 |
| PACS PACS Group, Inc. | $7.7B | 27.3 | +11.0% | +24.3% | 6 |
| AGL agilon health, inc. | $1.9B | — | +2.0% | +576.1% | 5 |
| Peer median | $31.7B | 35.9 | +9.7% | +77.7% | 27 |
P/E uses the latest reported trailing-12-month diluted EPS; "—" means no positive earnings or no data.
Short Interest & Float
Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.
Metric definitions
- Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
- SI % of Float — short interest / free float. The key crowding metric.
- Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
- Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
- Free Float — shares available for public trading (total shares minus insider / restricted).
- Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
- SI % of Float < 5% — typical, no particular signal.
- 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
- 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
- >30% — extreme; borrow is likely expensive and squeeze risk is material.
- Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
- Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
- A sudden drop in SI after a rally may indicate a squeeze in progress.
Short interest is reported mid-month and end-of-month; short volume is daily.
Short Interest
4.33M
SI % of Float
9.41%
Days to Cover
5.48
Short Vol Ratio
69.5%
Free Float
46.07M
Float %
29.1%
Short interest 2026-10-15 • Short volume 2026-11-10 • Float 2026-05-15